The Economics of Strategies to Reduce Respiratory Syncytial Virus Hospitalizations in Alaska.

Borse, Rebekah H; Singleton, Rosalyn J; Bruden, Dana T; Fry, Alicia M; Hennessy, Thomas W; Meltzer, Martin I

Borse, Rebekah H; Singleton, Rosalyn J; Bruden, Dana T; Fry, Alicia M; Hennessy, Thomas W; Meltzer, Martin I.

Afiliação

Borse RH; Division of Preparedness and Emerging Infections.
Singleton RJ; Arctic Investigations Program, National Center for Emerging and Zoonotic Infectious Diseases.
Bruden DT; Arctic Investigations Program, National Center for Emerging and Zoonotic Infectious Diseases.
Fry AM; Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Hennessy TW; Arctic Investigations Program, National Center for Emerging and Zoonotic Infectious Diseases.
Meltzer MI; Division of Preparedness and Emerging Infections.

J Pediatric Infect Dis Soc ; 3(3): 201-12, 2014 Sep.

Article em En | MEDLINE | ID: mdl-26625383

Palavras-chave

Alaska; Synagis; YKD; cost benefit; cost effectiveness; decision making; economics; healthcare costs; infants; palivizumab; respiratory syncytial virus

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies Idioma: En Revista: J Pediatric Infect Dis Soc Ano de publicação: 2014 Tipo de documento: Article País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google